Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $23.63 billion. The enterprise value is $19.14 billion.
| Market Cap | 23.63B |
| Enterprise Value | 19.14B |
Important Dates
The next confirmed earnings date is Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 202.70 million shares outstanding. The number of shares has increased by 3.09% in one year.
| Current Share Class | 202.70M |
| Shares Outstanding | 202.70M |
| Shares Change (YoY) | +3.09% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | 0.47% |
| Owned by Institutions (%) | 87.49% |
| Float | 170.41M |
Valuation Ratios
The trailing PE ratio is 14.85 and the forward PE ratio is 59.21. Incyte's PEG ratio is 5.41.
| PE Ratio | 14.85 |
| Forward PE | 59.21 |
| PS Ratio | 4.06 |
| Forward PS | 4.03 |
| PB Ratio | 3.69 |
| P/TBV Ratio | 3.87 |
| P/FCF Ratio | 12.31 |
| P/OCF Ratio | 11.94 |
| PEG Ratio | 5.41 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.85, with an EV/FCF ratio of 9.96.
| EV / Earnings | 11.87 |
| EV / Sales | 3.29 |
| EV / EBITDA | 9.85 |
| EV / EBIT | 10.38 |
| EV / FCF | 9.96 |
Financial Position
The company has a current ratio of 4.59, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.59 |
| Quick Ratio | 4.31 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.02 |
| Interest Coverage | 793.13 |
Financial Efficiency
Return on equity (ROE) is 30.67% and return on invested capital (ROIC) is 86.52%.
| Return on Equity (ROE) | 30.67% |
| Return on Assets (ROA) | 16.83% |
| Return on Invested Capital (ROIC) | 86.52% |
| Return on Capital Employed (ROCE) | 28.11% |
| Weighted Average Cost of Capital (WACC) | 8.31% |
| Revenue Per Employee | $2.05M |
| Profits Per Employee | $566,942 |
| Employee Count | 2,844 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 26.34 |
Taxes
In the past 12 months, Incyte has paid $354.98 million in taxes.
| Income Tax | 354.98M |
| Effective Tax Rate | 18.04% |
Stock Price Statistics
The stock price has increased by +27.74% in the last 52 weeks. The beta is 0.74, so Incyte's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +27.74% |
| 50-Day Moving Average | 120.99 |
| 200-Day Moving Average | 107.87 |
| Relative Strength Index (RSI) | 50.22 |
| Average Volume (20 Days) | 1,824,561 |
Short Selling Information
The latest short interest is 10.03 million, so 4.95% of the outstanding shares have been sold short.
| Short Interest | 10.03M |
| Short Previous Month | 9.99M |
| Short % of Shares Out | 4.95% |
| Short % of Float | 5.88% |
| Short Ratio (days to cover) | 6.50 |
Income Statement
In the last 12 months, Incyte had revenue of $5.82 billion and earned $1.61 billion in profits. Earnings per share was $7.85.
| Revenue | 5.82B |
| Gross Profit | 3.24B |
| Operating Income | 1.84B |
| Pretax Income | 1.97B |
| Net Income | 1.61B |
| EBITDA | 1.94B |
| EBIT | 1.84B |
| Earnings Per Share (EPS) | $7.85 |
Balance Sheet
The company has $4.54 billion in cash and $38.27 million in debt, with a net cash position of $4.50 billion or $22.19 per share.
| Cash & Cash Equivalents | 4.54B |
| Total Debt | 38.27M |
| Net Cash | 4.50B |
| Net Cash Per Share | $22.19 |
| Equity (Book Value) | 6.34B |
| Book Value Per Share | 31.57 |
| Working Capital | 4.71B |
Cash Flow
In the last 12 months, operating cash flow was $1.98 billion and capital expenditures -$59.24 million, giving a free cash flow of $1.92 billion.
| Operating Cash Flow | 1.98B |
| Capital Expenditures | -59.24M |
| Depreciation & Amortization | 98.28M |
| Net Borrowing | -4.64M |
| Free Cash Flow | 1.92B |
| FCF Per Share | $9.47 |
Margins
Gross margin is 55.66%, with operating and profit margins of 31.69% and 27.71%.
| Gross Margin | 55.66% |
| Operating Margin | 31.69% |
| Pretax Margin | 33.81% |
| Profit Margin | 27.71% |
| EBITDA Margin | 33.38% |
| EBIT Margin | 31.69% |
| FCF Margin | 33.00% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.09% |
| Shareholder Yield | -3.09% |
| Earnings Yield | 6.73% |
| FCF Yield | 8.13% |
Analyst Forecast
The average price target for Incyte is $129.54, which is 11.10% higher than the current price. The consensus rating is "Buy".
| Price Target | $129.54 |
| Price Target Difference | 11.10% |
| Analyst Consensus | Buy |
| Analyst Count | 28 |
| Revenue Growth Forecast (3Y) | 8.37% |
| EPS Growth Forecast (3Y) | 10.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 1, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 9.67 and a Piotroski F-Score of 6.
| Altman Z-Score | 9.67 |
| Piotroski F-Score | 6 |